Trial Outcomes & Findings for Pediatric Helmet CPAP Pilot Study (NCT NCT04764929)

NCT ID: NCT04764929

Last Updated: 2024-07-29

Results Overview

Tolerance is defined as the successful application and maintenance of helmet CPAP without any unplanned, prolonged (\>5 minutes) removals or disruptions.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

5 participants

Primary outcome timeframe

Four hours

Results posted on

2024-07-29

Participant Flow

Participant milestones

Participant milestones
Measure
Helmet CPAP
Patients in the Pediatric Intensive Care Unit (PICU) already receiving CPAP through a facemask or nasal prongs or mask for at least four hours but no more than 48 hours will be transitioned to the Vyatil nonpowered oxygen tent system (Rochester, NY) by trained respiratory therapists per the manufacture's instructions: patient's neck circumference will be measured with a soft tape measure to ensure appropriate sizing. The helmet will be connected to at least 30 liters per minute of high flow medical air with an oxygen blender. The expiratory limb will be attached to the positive end expiratory pressure (PEEP) valve (initially set at 5 centimeters of water pressure) connected to a high-efficiency particulate air (HEPA) filter to prevent any viral particles from being released into the environment. A disposable manometer will be used to measure the pressure within the helmet. Once the flow to the helmet interface is on, the helmet will be sealed and secured with the system's arm straps. Helmet CPAP: Vyatil nonpowered oxygen tent system
Overall Study
STARTED
5
Overall Study
COMPLETED
5
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Pediatric Helmet CPAP Pilot Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Helmet CPAP
n=5 Participants
Patients in the Pediatric Intensive Care Unit (PICU) already receiving CPAP through a facemask or nasal prongs or mask for at least four hours but no more than 48 hours will be transitioned to the Vyatil nonpowered oxygen tent system (Rochester, NY) by trained respiratory therapists per the manufacture's instructions: patient's neck circumference will be measured with a soft tape measure to ensure appropriate sizing. The helmet will be connected to at least 30 liters per minute of high flow medical air with an oxygen blender. The expiratory limb will be attached to the positive end expiratory pressure (PEEP) valve (initially set at 5 centimeters of water pressure) connected to a high-efficiency particulate air (HEPA) filter to prevent any viral particles from being released into the environment. A disposable manometer will be used to measure the pressure within the helmet. Once the flow to the helmet interface is on, the helmet will be sealed and secured with the system's arm straps. Helmet CPAP: Vyatil nonpowered oxygen tent system
Age, Categorical
<=18 years
5 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=99 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
Sex: Female, Male
Female
3 Participants
n=99 Participants
Sex: Female, Male
Male
2 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
1 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=99 Participants
Race (NIH/OMB)
White
0 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=99 Participants
Region of Enrollment
United States
5 Participants
n=99 Participants
Admission Diagnosis
Viral Bronchiolitis
3 Participants
n=99 Participants
Admission Diagnosis
Viral Pneumonia
2 Participants
n=99 Participants

PRIMARY outcome

Timeframe: Four hours

Tolerance is defined as the successful application and maintenance of helmet CPAP without any unplanned, prolonged (\>5 minutes) removals or disruptions.

Outcome measures

Outcome measures
Measure
Helmet CPAP
n=5 Participants
Patients in the Pediatric Intensive Care Unit (PICU) already receiving CPAP through a facemask or nasal prongs or mask for at least four hours but no more than 48 hours will be transitioned to the Vyatil nonpowered oxygen tent system (Rochester, NY) by trained respiratory therapists per the manufacture's instructions: patient's neck circumference will be measured with a soft tape measure to ensure appropriate sizing. The helmet will be connected to at least 30 liters per minute of high flow medical air with an oxygen blender. The expiratory limb will be attached to the positive end expiratory pressure (PEEP) valve (initially set at 5 centimeters of water pressure) connected to a high-efficiency particulate air (HEPA) filter to prevent any viral particles from being released into the environment. A disposable manometer will be used to measure the pressure within the helmet. Once the flow to the helmet interface is on, the helmet will be sealed and secured with the system's arm straps. Helmet CPAP: Vyatil nonpowered oxygen tent system
Number of Participants Who Tolerated CPAP Helmet for at Least Four Hours
5 Participants

SECONDARY outcome

Timeframe: 4 hours

Population: Data was not collected thus cannot be analyzed or reported.

Respiratory rate will be measured in breaths per minute every hour for four hours.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 4 hours

Population: Data was not collected thus cannot be analyzed or reported.

Heart rate will be measured in beats per minute every hour for 4 hours.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 4 hours

Population: Data was not collected thus cannot be analyzed or reported.

Pulse oxygen saturation will be measured as a percent every hour for 4 hours.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 4 hours

Population: Data was not collected thus cannot be analyzed or reported.

Systolic blood pressure will be measured in millimeters of mercury every hour for 4 hours.

Outcome measures

Outcome data not reported

Adverse Events

Helmet CPAP

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Patrick Wilson, MD

Columbia University

Phone: 212-305-8458

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place